Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 11,733

Document Document Title
WO/2015/173553A1
The present invention relates to monocrystalline metal organic frameworks comprising chromium ions and carboxylate ligands and the use of the same, for example their use for storing a gas. The invention also relates to methods for prepar...  
WO/2015/175130A1
There is provided a composition which is capable of being separated into diastereomeric pairs of enantiomers. The compound has (Formula I) In Formula I: Ar' can be aryl or deuterated aryl; R1 can be H, D, alkyl, silyl, aryl, or a deutera...  
WO/2015/169763A1
The present invention relates to porphyrins of formula (I): wherein R1 to R6, R1' to R6', X, X' Y and Y' are as described in claim 1. The invention also relates to complexes of said porphyrins with transition metals, in particular iron, ...  
WO/2015/088867A3
Use a solvent blend that contains 1-methoxy-2,7-octadiene and an alkanols rather than the alkanols by itself to prepare a catalyst precursor suitable for use in butadiene telomerization.  
WO/2015/171095A1
The invention relates to the methods for synthesis, chemical structure and in vivo and in vitro anticancer effects of a palladium complex([Pd(bpma)(barb)]X•H2O) with high anticancer activity.  
WO/2015/165781A1
The present invention deals with the synthesis and applications of new cationic compounds being useful as metal ligands. Specifically, N-alkyl/aryl substituted pyridiniophosphines are prepared and used as ligands for transition metals. T...  
WO/2015/167216A1
The present invention relates to a photocleavable mass tag material and a use thereof. The photocleavable mass tag material of the present invention can be used for the detection and quantitative analysis of a biomarker, and can be used ...  
WO/2015/166498A1
The present invention concerns Pt (IV) lipophilic derivatives for improved drug performance in cancer therapy, as well as nanocarriers comprising them.  
WO/2015/163090A1
 An alkoxide compound represented by general formula (I). (In the formula, R1-R3 each independently represent hydrogen, a C1-12 hydrocarbon group, or the like. R4 represents a C1-12 hydrocarbon group or the like. L represents hydrogen,...  
WO/2015/009841A3
The present disclosure relates to novel platinum compositions having a heterocycle ligand and nanoparticles and methods using such compositions, e.g. for treating cancer. The present teachings relate to compositions termed herein "platin...  
WO/2015/163174A1
 Provided is a light-emitting element that has excellent external quantum efficiency. A light-emitting element that has a positive electrode, a negative electrode, a first light-emitting layer provided between the positive electrode an...  
WO/2015/163440A1
 The present invention provides a novel ruthenium complex that is easy to produce and handle and that can be supplied relatively inexpensively, a method for producing this ruthenium complex, a method for producing alcohols and the like...  
WO/2015/159744A1
A composition containing: a phosphorescence-emitting compound having a maximum peak wavelength in an emission spectrum of at least 380 nm and less than 495 nm, not having a dendron, and indicated by formula (1'); at least two types of de...  
WO/2015/159225A1
An organometallic complex of a tridentate bis(phosphine)-carbodicarbene ligand and a transition metal, is described. In some embodiments the ligand has the structure of Formula (I): The complexes are useful in methods of making an allyli...  
WO/2015/160224A1
The present invention relates to a multi-component host material and an organic electroluminescent device comprising the same. By comprising a specific combination of the multi-component host compounds, the organic electroluminescent dev...  
WO/2015/156703A2
The invention relates to the field of chemical technology of organic silicon compounds, in particular, to functional metallosiloxanes, products of their partial hydrolysis, the method of their preparation, and to their use as crosslin...  
WO/2015/151914A1
 The purpose of the present invention is to provide a method for synthesizing an organic metal complex having a substituent that has ligating properties to a central metal ion. This method for synthesizing an organic metal complex is c...  
WO/2015/150203A1
Cyclometallated Ir complex comprising three N,N diaryl substituted carbene ligands, bearing substituents in the 2 position of the non-cyclometallated aryl ring;an organic electronic device, preferably an organic light-emitting diode (OLE...  
WO/2015/149677A1
Described herein are novel platinum (II) emitters. These material show high emission quantum efficiency, low self‐quenching constant and stable in thermal deposition process. The OLED fabricated from these materials can have pure green...  
WO/2015/144759A1
The invention relates to prodrug compounds comprising a Co3+ ion and aquinazoline tyrosine kinase inhibitor moiety, wherein the quinazoline tyrosine kinase inhibitor moiety comprises a Co3+ -chelating moiety and wherein the quinazoline t...  
WO/2015/142684A1
The present invention relates to the compounds of formula (I), pharmaceutically acceptable salts, and solvates thereof, wherein the various substituents are as defined herein. The compounds, solvates and salts thereof of Formula (I) are ...  
WO/2015/141603A1
A metal complex indicated by general formula (1). (1) [In the formula, M indicates an iridium atom or a platinum atom, n1 indicates 1-3, n2 indicates 0-2, A1-G1-A2 indicates an anionic bidentate ligand, m1 and m2 indicate 3 or 4, E1-E4 i...  
WO/2015/142683A1
Newly synthesized thiourea-modified 3-chloro-4-fluoroanilio-quinazoline derivatives have been studied, as terminal carrier ligands in linear gold(I) complexes. The molecules mimic the tyrosine kinase inhibitor gefitinib (by computational...  
WO/2015/140337A1
The present invention relates to hybrid fumarate-CO-releasing molecules capable of increasing heme oxygenase-1 (HO-1) activity and HO-1 protein expression and simultaneously releasing CO, their synthesis and their use in therapeutic appl...  
WO/2015/139060A1
Described herein is the fusion of two families of unique carbon-containing molecules that readily disregard the tendency of carbon to form four chemical bonds, namely N-heterocyclic carbenes (NHCs) and carborane anions. Deprotonation of ...  
WO/2015/136913A1
 This method for producing a surface-modified substrate includes a step for bringing into contact, in the presence of a borane catalyst, a substrate having polar groups present on the surface thereof and a hydrosilane compound having a...  
WO/2015/137496A1
The present invention provides a process for efficiently producing an optically active 6-(3-aminopiperidin-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimi dine derivative. 1,4,5,6-tetrahydropyridine-3-carboxamide or a derivative thereof is asym...  
WO/2015/137194A1
 A neutral or cationic mononuclear ruthenium divalent complex represented by formula (1) can actualize exceptional catalytic activity in at least one reaction among a hydrosilylation reaction, hydrogenation reaction, and carbonyl compo...  
WO/2015/137272A1
The present invention provides a porous structure containing at least two kinds of metal ions and an organic ligand, said porous structure being characterized in that the at least two kinds of metal ions are homogeneously mixed together ...  
WO/2015/136845A1
Provided are a novel iridium complex and an organic EL element using the novel iridium complex. This iridium complex contains an Ir atom and a first ligand that is coordinated to the Ir atom and is represented by formula (L1). (In the fo...  
WO/2015/134663A1
Disclosed herein are processes for dehydrogenation of an alkane to an alkene using an iridium pincer complex. In the dehydrogenation reactions, hydrogen that is co-formed during the process must be removed for the chemical reaction to pr...  
WO/2015/130080A1
The present invention relates to a novel iridium (III) complex compound capable of being solution-processed and an organic electroluminescent device comprising same, and more specifically, to a novel iridium (III) complex compound into w...  
WO/2015/130780A1
There is provided a compound having Formula II In Formula II: R1- R4 are the same or different at each occurrence and can be D, alkyl, silyl, aryl, deuterated alkyl, deuterated silyl, or deuterated aryl; a and c are the same or different...  
WO/2015/131158A1
Chiral metal complexes having one of general formulae (1)-(4).  
WO/2015/129813A1
The present invention provides: a deuteration method that is both cost effective and has an excellent deuteration rate; a method for selectively replacing a leaving group of an aromatic compound with deuterium; and a deuteration catalyst...  
WO/2015/129994A1
The present invention relates to a novel red light-emitting iridium (III) complex compound capable of being solution-processed, and more specifically, to a novel iridium (III) complex compound into which a picolinic acid derivative is in...  
WO/2015/126400A1
Monocyclic N-pyridyl-1,4-azaborines and their Pt coordination complexes.  
WO/2015/127037A1
In some embodiments, the present disclosure pertains to a composition for modulating the expression of at least one gene associated with neuronal cell survival or stability. In some embodiments, the present disclosure provides for compos...  
WO/2015/089389A8
Pt(IV) prodrugs include one or more conjugated cyclooxygenase inhibitor. Reduction of Pt(IV) to Pt(II) can result cisplatin and a cyclooxygenase inhibitor. For proof of concept, a Pt(IV) prodrug that can produce cisplatin and aspirin, Pl...  
WO/2015/121150A1
The present invention relates to a water suspension of graphene oxide nanoflakes decorated by nanoparticles of metallic platinum, characterised in that it comprises: • 100μg/ml to 500μg/ml of graphene oxide nanoflakes, • 5μg/ml to...  
WO/2015/122502A1
The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in ...  
WO/2015/117718A1
The invention relates to metal complexes and to electronic devices, in particular organic electroluminescence devices, containing said metal complexes.  
WO/2015/102020A4
The present invention relates to novel N-heterocyclic carbenes compounds and process of the preparation thereof. The present invention further relates to the use of use of these novel N-heterocyclic carbenes as ligand in the Suzuki-Miyau...  
WO/2015/118134A1
The present invention relates to platinum complexes with diazabicyclo- hydrocarbon compounds of the general formula (I), processes for preparing said complexes and the use thereof as pharmaceutically active compounds, in particular as cy...  
WO/2015/120391A1
The disclosure provides nanostructures (e.g., nanospheres and nano-paddlewheels) formed through transition metal-ligand (e.g., Pd(II)-, Ni(II)-, or Fe(II)-ligand of Formula (A)) coordination and junction self-assembly. The disclosure als...  
WO/2015/115937A1
The invention relates to the field of homogeneous catalysis and concerns the production of dicyclopentadiene metathesis polymerization catalysts. The present dicyclopentadiene polymerization catalyst in the form of a ruthenium complex is...  
WO/2015/115938A1
The invention relates to the field of homogeneous catalysis and concerns the production of a catalyst for the metathesis polymerization of dicyclopentadiene. A ruthenium catalyst for the polymerization of dicyclopentadiene consists of...  
WO/2015/115939A1
The invention relates to the field of catalysis and concerns the production of catalysts for the polymerization of dicyclopentadiene. A polymerization catalyst having general formula (I), where (II) is a fundamentally novel substituen...  
WO/2015/110515A1
A process for the hydrogenation of a substrate comprising a carbon heteroatom double bond in the presence of a transition metal complex comprising a tridentate or bisdentate- ligand containing a nitrogen, sulphur and phosphorus atom, of ...  
WO/2015/033313A3
The present disclosure relates to abnormal N-Heterocyclic Carbene complexes. The present disclosure also relates to synthesis, characterization and applications of abnormal N-Heterocyclic Carbene Complex.  

Matches 551 - 600 out of 11,733